1000 peer reviewed articles on “Vaccine” injuries
その中で2番目に多くの件数が報告されている血栓症の論文リストにリンクをつけていたら、30000文字オーバーということで、投稿できなくなりましたので後半を分割しました。
Comments on thrombosis after vaccination: spike protein leader sequence could be responsible for thrombosis and antibody-mediated thrombocytopenia:
https://pubmed.ncbi.nlm.nih.gov/34788138
Thrombosis in pre- and post-vaccination phase of COVID-19;
https://pubmed.ncbi.nlm.nih.gov/34650382/
Vaccine-associated thrombocytopenia and thrombosis: venous endotheliopathy leading to combined venous micro-macrothrombosis:
https://pubmed.ncbi.nlm.nih.gov/34833382/
Thrombosis and thrombocytopenia syndrome causing isolated symptomatic carotid occlusion after COVID-19 Ad26.COV2.S vaccine (Janssen):
https://pubmed.ncbi.nlm.nih.gov/34670287/
An unusual presentation of acute deep vein thrombosis after Modern COVID-19 vaccine: case report: https://pubmed.ncbi.nlm.nih.gov/34790811/
Immediate high-dose intravenous immunoglobulins followed by direct treatment with thrombin inhibitors is crucial for survival in vaccine-induced immune thrombotic thrombocytopenia Sars-Covid-19-vector adenoviral VITT with venous thrombosis of the cerebral sinus and portal vein:
https://pubmed.ncbi.nlm.nih.gov/34023956/
.
Thrombosis formation after COVID-19 vaccination immunologic aspects: review article:
https://pubmed.ncbi.nlm.nih.gov/34629931/
Imaging and hematologicfindings in thrombosis and thrombocytopenia after vaccination with ChAdOx1 nCoV-19 (AstraZeneca):
https://pubmed.ncbi.nlm.nih.gov/34402666/
Cerebral venous sinus thrombosis, pulmonary embolism, and thrombocytopenia after COVID-19 vaccination in a Taiwanese man: a case report and review of the literature:
https://pubmed.ncbi.nlm.nih.gov/34630307/
Fatal cerebral venous sinus thrombosis after COVID-19 vaccination:
https://pubmed.ncbi.nlm.nih.gov/33983464/
Autoimmune roots of thrombotic events after COVID-19 vaccination:
https://pubmed.ncbi.nlm.nih.gov/34508917/
.
New portal vein thrombosis in cirrhosis: is thrombophilia exacerbated by vaccine or COVID-19
https://www.jcehepatology.com/article/S0973-6883(21)00545-4/fulltext
.
Cerebral venous sinus thrombosis after vaccination with COVID-19 mRNA of BNT162b2:
https://pubmed.ncbi.nlm.nih.gov/34796065/
.
A case of unusual mild clinical presentation of COVID-19 vaccine-induced immune thrombotic thrombocytopenia with splanchnic vein thrombosis:
https://pubmed.ncbi.nlm.nih.gov/34843991/
Cerebral venous sinus thrombosis following vaccination with Pfizer-BioNTech COVID-19 (BNT162b2): https://pubmed.ncbi.nlm.nih.gov/34595867/
A case of idiopathic thrombocytopenic purpura after a booster dose of COVID-19 BNT162b2 vaccine (Pfizer-Biontech):
https://pubmed.ncbi.nlm.nih.gov/34820240/
Vaccine-induced immune thrombotic immune thrombocytopenia (VITT): targeting pathologic mechanisms with Bruton’s tyrosine kinase inhibitors:
https://pubmed.ncbi.nlm.nih.gov/33851389/
Thromboembolic events in younger females exposed to Pfizer-BioNTech or Moderna COVID-19 vaccines: https://pubmed.ncbi.nlm.nih.gov/34264151/
Thrombosis after adenovirus-vectored COVID-19 vaccination: a concern for underlying disease:
https://pubmed.ncbi.nlm.nih.gov/34755555/
Unusual site of deep vein thrombosis after vaccination against coronavirus mRNA-2019 coronavirus disease (COVID-19):
https://pubmed.ncbi.nlm.nih.gov/34840204/
Deep venous thrombosis after vaccination with Ad26.COV2.S in adult males:
https://pubmed.ncbi.nlm.nih.gov/34659839/
.
Clinical and biological features of cerebral venous sinus thrombosis after vaccination with ChAdOx1 nCov-19;
https://jnnp.bmj.com/content/early/2021/09/29/jnnp-2021-327340
.
COV2-S vaccination may reveal hereditary thrombophilia: massive cerebral venous sinus thrombosis in a young man with normal platelet count:
https://pubmed.ncbi.nlm.nih.gov/34632750/
Post-mortemfindings in vaccine-induced thrombotic thrombocytopenia:
https://haematologica.org/article/view/haematol.2021.279075
COVID-19 vaccine-induced thrombosis:
https://pubmed.ncbi.nlm.nih.gov/34802488/
.
Inflammation and platelet activation after COVID-19 vaccines: possible mechanisms behind vaccine-induced immune thrombocytopenia and thrombosis:
https://pubmed.ncbi.nlm.nih.gov/34887867/
.
Anaphylactoid reaction and coronary thrombosis related to COVID-19 mRNA vaccine:
https://pubmed.ncbi.nlm.nih.gov/34863404/
.
Occurrence of splenic infarction due to arterial thrombosis after vaccination with COVID-19:
https://pubmed.ncbi.nlm.nih.gov/34876440/
Deep venous thrombosis more than two weeks after COVID-19 vaccination:
https://pubmed.ncbi.nlm.nih.gov/33928773/
Information on ChAdOx1 nCoV-19 vaccine-induced immune-mediated thrombotic thrombocytopenia:
https://pubmed.ncbi.nlm.nih.gov/34587242/
Management of a patient with a rare congenital limb malformation syndrome after SARS-CoV-2 vaccine-induced thrombosis and thrombocytopenia (VITT):
https://pubmed.ncbi.nlm.nih.gov/34097311/
Thrombocytopenia and splanchnic thrombosis after vaccination with Ad26.COV2.S successfully treated with transjugular intrahepatic intrahepatic portosystemic shunt and thrombectomy:
https://onlinelibrary.wiley.com/doi/10.1002/ajh.26258
Chang, J. C., & Hawley, H. B. (2021). Vaccine-Associated Thrombocytopenia and Thrombosis: Venous Endotheliopathy Leading to Venous Combined Micro-Macrothrombosis. Medicina (Kaunas), 57(11). doi:10.3390/medicina57111163.
https://www.ncbi.nlm.nih.gov/pubmed/34833382
Potential risk of thrombotic events after COVID-19 vaccination with Oxford-AstraZeneca in women receiving estrogen:
https://pubmed.ncbi.nlm.nih.gov/34734086/
Thrombotic adverse events reported for Moderna, Pfizer, and Oxford-AstraZeneca COVID-19 vaccines: comparison of occurrence and clinical outcomes in the EudraVigilance database:
https://pubmed.ncbi.nlm.nih.gov/34835256/
Predicted and observed incidence of thromboembolic events among Koreans vaccinated with the ChAdOx1 nCoV-19 vaccine:
https://pubmed.ncbi.nlm.nih.gov/34254476/
Three cases of acute venous thromboembolism in women after coronavirus 2019 vaccination:
https://pubmed.ncbi.nlm.nih.gov/34352418/
Shazley, O., & Alshazley, M. (2021). A COVID-Positive 52-Year-Old Man Presented With Venous Thromboembolism and Disseminated Intravascular Coagulation Following Johnson & Johnson Vaccination: A Case-Study. Cureus, 13(7), e16383.doi:10.7759/cureus.16383.?
https://www.ncbi.nlm.nih.gov/pubmed/34408937
